• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    Trending Down-0.0001 (-99.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0001
  • Day Range
    Low 0.0000
    High 0.0000
  • 52 Week Range
    Low 0.0000
    High 0.1789
  • Volume
    370
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.0001
TimeVolumeONPH
10:13 ET3501E-06
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesONPH
Oncology Pharma Inc
3.9K
0.0x
---
United StatesLSDIF
Lucy Scientific Discovery Inc
10.6K
0.0x
---
United StatesPLTT
Pilot Therapeutics Holdings Inc
1.2K
0.0x
---
United StatesCALA
Calithera Biosciences Inc
36.1K
0.0x
---
United StatesSIGO
Sunset Island Group Inc
590.0
0.0x
---
United StatesMDCN
Medican Enterprises Inc
38.9K
0.0x
---
As of 2024-11-22

Company Information

Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.

Contact Information

Headquarters
One Sansome Street,, Suite 3500SAN FRANCISCO, CA, United States 94104
Phone
415-869-1036
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.9K
Revenue (TTM)
$29.5K
Shares Outstanding
38.6M
Oncology Pharma Inc does not pay a dividend.
Beta
-2.55
EPS
$-20,154,790.00
Book Value
---
P/E Ratio
0.0x
Price/Sales (TTM)
0.1
Price/Cash Flow (TTM)
---
Operating Margin
-75,237.89%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.